A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances
Jesper T Andreasen, John P Redrobe, Elsebet Ø Nielsen, Jeppe K Christensen, Gunnar M Olsen, Dan Peters
10Citations
(Scopus)
Fingerprint
Dive into the research topics of 'A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances'. Together they form a unique fingerprint.